myelodysplastic syndrome
A clonal hematopoietic disorder characterized by dysplasia and ineffective hematopoiesis in one or more of the hematopoietic cell lines. The dysplasia may be accompanied by an increase in myeloblasts, but the number is less than 20%, which, according to the WHO guidelines, is the requisite threshold for the diagnosis of acute myeloid leukemia. It may occur de novo or as a result of exposure to alkylating agents and/or radiotherapy. (WHO, 2001) [ NCIT:C3247 ]
Term info
- SCTID:109995007 (MONDO:equivalentTo)
- ICDO:9989/3 (NCIT:C3247)
- DOID:0050908 (MONDO:equivalentTo)
- Orphanet:52688 (OMIM:614286)
- ONCOTREE:MDS (MONDO:equivalentTo)
- GARD:0007132 (MONDO:equivalentTo)
- EFO:0000198 (MONDO:equivalentTo)
- UMLS:C3463824 (Orphanet:52688)
- OMIM:614286 (Orphanet:52688/e)
- ICD9:238.7 (DOID:0050908)
- UMLS:C0033027 (MONDO:equivalentTo)
- NCIT:C3247 (MONDO:equivalentTo)
- MedDRA:10028532 (Orphanet:52688/e)
- ICD9:238.75 (MONDO:i2s)
disease_grouping, ordo_group_of_disorders
https://github.com/monarch-initiative/mondo/issues/5268, https://github.com/monarch-initiative/mondo/issues/4521
http://identifiers.org/meddra/10028532
A clonal hematopoietic disorder characterized by dysplasia and ineffective hematopoiesis in one or more of the hematopoietic cell lines. The dysplasia may be accompanied by an increase in myeloblasts, but the number is less than 20%, which, according to the WHO guidelines, is the requisite threshold for the diagnosis of acute myeloid leukemia. It may occur de novo or as a result of exposure to alkylating agents and/or radiotherapy. (WHO, 2001)
http://purl.obolibrary.org/obo/Orphanet_52688, https://omim.org/entry/614286, http://linkedlifedata.com/resource/umls/id/C3463824, http://purl.obolibrary.org/obo/NCIT_C3247, http://linkedlifedata.com/resource/umls/id/C0033027, http://purl.obolibrary.org/obo/DOID_0050908, http://identifiers.org/snomedct/109995007
oligoblastic leukemia, MDS, unclassifiable, preleukemia, myelodysplastic syndrome, somatic, myelodysplastic neoplasm, dysmyelopoietic syndrome, myelodysplasia, hematopoeitic - myelodysplastic syndrome (MDS), smoldering leukemia, myelodysplastic syndrome, unclassifiable, myelodysplastic syndromes, MDS-U, myelodysplastic syndrome/neoplasm, myelodysplastic syndrome, MDS
myelodysplastic syndrome, susceptibility to
MONDO:0018881
Term relations
- neoplastic syndrome
- myeloid hemopathy
- disease has feature some myeloid neoplasm
- disease has feature some bone marrow cancer